NCT05010785

Brief Summary

Sohn introduced the concept of sticky bone in which i-PRF is mixed with the granules of bone graft, leading to fabrication of growth factors-enriched bone graft matrix using autologous fibrin glue. This minimizes bone loss and accelerates tissue healing during healing period. The present study was conducted to evaluate the clinical and radiographic outcomes following the application of the alveolar ridge splitting in combination with the use of guided bone regeneration (GBR) with or without i-PRF (sticky bone), associated with immediate implant placement in patients with horizontally atrophic jaw bones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 18, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

August 20, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2022

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2022

Completed
Last Updated

December 22, 2023

Status Verified

December 1, 2023

Enrollment Period

1.2 years

First QC Date

August 1, 2021

Last Update Submit

December 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurements of the amount of bone formation in millimeters around immediately placed dental implants

    Measurements of the amount of bone formation in millimeters using GBR with or without the combined effect of i-PRF in the ridge splitting following immediate implant placement.

    9 months

Study Arms (2)

alveolar ridge splitting with GBR and i-PRF

EXPERIMENTAL

alveolar ridge splitting in combination with the use of GBR with i-PRF (sticky bone) with immediate implant placement

Procedure: Immediate implant placement and alveolar ridge splitting with GBR and i-PRF

alveolar ridge splitting with GBR

ACTIVE COMPARATOR

alveolar ridge splitting in combination with the use of GBR without i-PRF (sticky bone) with immediate implant placement

Procedure: Immediate implant placement and alveolar ridge splitting with GBR

Interventions

Implant insertion and GBR for augmentation of the gap between buccal and lingual plate using bone graft mixed with i-PRF

alveolar ridge splitting with GBR and i-PRF

Implant insertion and GBR for augmentation of the gap between buccal and lingual plate

alveolar ridge splitting with GBR

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • good general health at the time of surgery.
  • at least 3 months of healing after tooth extraction.
  • horizontally compromised alveolar ridges at least 10 mm high and 3 mm wide.

You may not qualify if:

  • a vertical bone defect in the edentulous ridge.
  • thick cortex in the labial/buccal with less cancellous bone inside
  • obvious undercut on the labial/buccal side.
  • uncontrolled periodontal conditions or other oral disorders.
  • history of radiotherapy in the head and neck region.
  • uncontrolled diabetes mellitus or other systematic disorders.
  • smokers.
  • Pregnancy.
  • non-compliant patients.
  • allergic reaction to the medications used

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Kafrelsheikh University

Kafr ash Shaykh, 33511, Egypt

Location

MeSH Terms

Interventions

proliferation regulatory factors, human urine

Study Officials

  • Dalia R Issa, PhD

    Kafrelsheikh University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

August 1, 2021

First Posted

August 18, 2021

Study Start

August 20, 2021

Primary Completion

November 3, 2022

Study Completion

November 15, 2022

Last Updated

December 22, 2023

Record last verified: 2023-12

Locations